Processing
Collecting data for RIGL and 1037 ...

Asset Comparison and Correlation

View All Portfolios

More Actions
- Select Assests
- Optimize Portfolio
- Suggest Portfolio
- Backtest Watchlist
- Analyze Correlations
- View Transactions
- Check Volatilities
- Import Equities
- Search Equities

Investment horizon:

30 Days Login to change

Run Correlation

Rigel Pharmaceuticals Inc. vs Daiwa Associate Holdings Ltd.

Compare Fundamentals

Daily Returns (%)

1037

RIGL

Embed

Export

Timeline

Given investment horizon of 30 days, Rigel Pharmaceuticals Inc is expected to generate 0.7 times more return on investment than Daiwa. However, Rigel Pharmaceuticals Inc is 1.43 times less risky than Daiwa. It trades about 0.03 of its potential returns per unit of risk. Daiwa Associate Holdings Ltd is currently generating about -0.23 per unit of risk. If you would invest 473.00 in Rigel Pharmaceuticals Inc on April 18, 2013 and sell it today you would earn a total of 1.00 from holding Rigel Pharmaceuticals Inc or generate 0.21% return on investment over 30 days.

Diversification

Very weak diversification

Overlapping area represents amount of risk that can be diversified away by holding Rigel Pharmaceuticals Inc. and Daiwa Associate Holdings Ltd. in the same portfolio assuming nothing else is changed

Optimize

Correlation Coefficient

0.5

Parameters

Time Period	1 Month [change]
Direction	Positive
Strength	Weak
Accuracy	86.36%
Values	Daily Returns

Suggest

Follow Correlation between RIGL and 1037 with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker

Get Widget

Add Correlation between RIGL and 1037 to your reader

Syndicate

Share Correlation between RIGL and 1037

Find Opportunities

Predicted Return Density

Embed

Export

Returns

1037

RIGL

Rigel Pharmaceuticals Inc

Alpha

Profile

Rigel

Performance

1	Out Of 100

Over 30

Days

99% of all equities and portfolios perform better than Rigel Pharmaceuticals Inc. Compared with the overall equity markets, risk-adjusted returns on investments in Rigel Pharmaceuticals Inc are ranked lower than 1 (%) of all global equities and portfolios over the last 30 days.

Check Performance

Backtest

Predict Price